Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin.
Nicolás MerchanteRocío HerreroMaría Dolores Valverde-FredetMiguel Rodríguez-FernándezHéctor PinagorteFrancisco J Martínez-MarcosConcepción Gil-AnguitaMaría García-LópezMaría Tasias PitarchVicente Abril López De MedranoMiguel Nicolás Navarrete LoriteCristina Gómez-AyerbeEva LeónPilar González-De La AlejaAna Ruiz CastilloAna I AllerJuan Carlos Rodríguez-DiazJulia Ternero FonsecaJuan E CorzoAlberto Naranjo PérezMarta Trigo-RodríguezEsperanza MerinoPublished in: JAC-antimicrobial resistance (2023)
Recent use of piperacillin/tazobactam might be associated with a lower risk of CDI recurrence, while recent use of cephalosporins might promote an increased risk. These findings should be considered when treating hospitalized patients.